映恩生物-B（股票代码：09606）于2026年4月9日发布截至2026年3月31日的股份变动月报表。根据公告，公司本月注册股本仍为200,000,000股，面值USD 0.0001，注册股本金额维持20,000美元不变。
报告期内，已发行股份由上月底的90,137,714股增至90,238,014股，新增发行股份共100,300股，均来自公司首次公开发售前股权激励计划的期权行使。该行权共为公司带来637,734港元资金（约占本月新增发行股份资金总额）。公司当月无股份回购或注销活动，库存股份保持为零。
截至本月末，公司已发行股份总数为90,238,014股，股本规模小幅增加。公司同时确认遵守香港联交所《上市规则》和相关法律规定。公告由联席公司秘书袁佳丽签署。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.